Related references
Note: Only part of the references are listed.Prioritising attributes for tuberculosis preventive treatment regimens: a modelling analysis
Juan F. Vesga et al.
BMC MEDICINE (2022)
Digital health use in latent tuberculosis infection care: A systematic review
Yen Jun Wong et al.
INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS (2022)
Safety and Efficacy of Rifampin or Isoniazid Among People With Mycobacterium tuberculosis Infection and Living With Human Immunodeficiency Virus or Other Health Conditions: Post Hoc Analysis of 2 Randomized Trials
Jonathon R. Campbell et al.
CLINICAL INFECTIOUS DISEASES (2021)
A systematic review and meta-analysis of non-adherence to anti-diabetic medication: Evidence from low- and middle-income countries
Md Azharuddin et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)
Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials
Jonathon R. Campbell et al.
LANCET INFECTIOUS DISEASES (2020)
Risk of active tuberculosis development in contacts exposed to infectious tuberculosis in congregate settings in Korea
Shin Young Park et al.
SCIENTIFIC REPORTS (2020)
Accuracy of machine learning-based prediction of medication adherence in clinical research
Vidya Koesmahargyo et al.
PSYCHIATRY RESEARCH (2020)
Adherence in Hypertension A Review of Prevalence, Risk Factors, Impact, and Management
Michel Burnier et al.
CIRCULATION RESEARCH (2019)
Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults
D. Menzies et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection A Randomized Trial
Robert Belknap et al.
ANNALS OF INTERNAL MEDICINE (2017)
Treatment of Latent Tuberculosis Infection An Updated Network Meta-analysis
Dominik Zenner et al.
ANNALS OF INTERNAL MEDICINE (2017)
Interventions for improving adherence to treatment for latent tuberculosis infection: a systematic review
Anke L. Stuurman et al.
BMC INFECTIOUS DISEASES (2016)
Factors Associated With Noncompletion of Latent Tuberculosis Infection Treatment: Experience From the PREVENT TB Trial in the United States and Canada
Ruth N. Moro et al.
CLINICAL INFECTIOUS DISEASES (2016)
Risk of developing tuberculosis disease among persons diagnosed with latent tuberculosis infection in the Netherlands
Connie G. M. Erkens et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling
Rein M. G. J. Houben et al.
PLOS MEDICINE (2016)
Psychological factors predict adherence to methotrexate in rheumatoid arthritis; findings from a systematic review of rates, predictors and associations with patient-reported and clinical outcomes
Holly F. Hope et al.
RMD OPEN (2016)
Medication Adherence in Gout: A Systematic Review
Mary A. De Vera et al.
ARTHRITIS CARE & RESEARCH (2014)
Factors associated with adherence to pharmaceutical treatment for rheumatoid arthritis patients: A systematic review
Annelieke Pasma et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2013)
The roles of past behavior and health beliefs in predicting medication adherence to a statin regimen
Todd D. Molfenter et al.
PATIENT PREFERENCE AND ADHERENCE (2012)
Adverse Events with 4 Months of Rifampin Therapy or 9 Months of Isoniazid Therapy for Latent Tuberculosis Infection
Dick Menzies et al.
ANNALS OF INTERNAL MEDICINE (2008)
Share Paper
